Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Selective progesterone receptor modulators in early stage breast cancer: a randomized, placebo-controlled Phase II window of opportunity trial using telapristone acetate.

Lee O, Sullivan ME, Xu Y, Rodgers C, Muzzio M, Helenowski I, Shidfar A, Zeng Z, Singhal H, Jovanovic B, Hansen N, Bethke KP, Gann PH, Gradishar W, Kim JJ, Clare SE, Khan SA.

Clin Cancer Res. 2019 Sep 30. pii: clincanres.0443.2019. doi: 10.1158/1078-0432.CCR-19-0443. [Epub ahead of print]

PMID:
31570566
2.

Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.

Wang J, Shidfar A, Ivancic D, Ranjan M, Liu L, Choi MR, Parimi V, Gursel DB, Sullivan ME, Najor MS, Abukhdeir AM, Scholtens D, Khan SA.

Int J Cancer. 2017 Jun 1;140(11):2484-2497. doi: 10.1002/ijc.30680. Epub 2017 Mar 21.

3.

Expression of miR-18a and miR-210 in Normal Breast Tissue as Candidate Biomarkers of Breast Cancer Risk.

Shidfar A, Costa FF, Scholtens D, Bischof JM, Sullivan ME, Ivancic DZ, Vanin EF, Soares MB, Wang J, Khan SA.

Cancer Prev Res (Phila). 2017 Jan;10(1):89-97. doi: 10.1158/1940-6207.CAPR-16-0177. Epub 2016 Oct 27.

4.

Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid.

Shidfar A, Fatokun T, Ivancic D, Chatterton RT, Khan SA, Wang J.

Horm Cancer. 2016 Aug;7(4):252-9. doi: 10.1007/s12672-016-0264-3. Epub 2016 Apr 19.

PMID:
27094399
5.

Genetic Determinants of Nipple Aspiration Fluid Yield.

Shidfar A, Wang J, Wiesenfeld E, Zhang W, Scholtens D, Fought A, Chatterton RT, Khan SA.

Ann Surg Oncol. 2016 Aug;23(8):2487-93. doi: 10.1245/s10434-016-5163-x. Epub 2016 Mar 30.

PMID:
27027309
6.

Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.

Lee O, Ivancic D, Allu S, Shidfar A, Kenney K, Helenowski I, Sullivan ME, Muzzio M, Scholtens D, Chatterton RT Jr, Bethke KP, Hansen NM, Khan SA.

Cancer Chemother Pharmacol. 2015 Dec;76(6):1235-46. doi: 10.1007/s00280-015-2848-y. Epub 2015 Nov 11.

PMID:
26560487
7.

RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.

Hu H, Wang J, Gupta A, Shidfar A, Branstetter D, Lee O, Ivancic D, Sullivan M, Chatterton RT Jr, Dougall WC, Khan SA.

Breast Cancer Res Treat. 2014 Aug;146(3):515-23. doi: 10.1007/s10549-014-3049-9. Epub 2014 Jul 10.

PMID:
25007964

Supplemental Content

Loading ...
Support Center